DA
GCVRZ

David Abrams’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

David Abrams’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-11,658,873
Closed -$3.96M – 15
2013
Q4 		$3.96M Sell
11,658,873
-19,520,764
-63% -$23.6M 0.31% 10
2013
Q3 		$63M Sell
31,179,637
-89,450
-0.3% -$170K 4.93% 7
2013
Q2 		$59.4M Buy
+31,269,087
New +$54.9M 3.44% 10

Other funds holding GCVRZ

FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 14.02% 1-Year Est. Return
MCM
Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

David Abrams's GCVRZ Position: Q1 2014 in Review

David Abrams sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2014, closing a stake of 11,658,873 shares — an estimated $3.96M sold.

David Abrams first reported a position in GCVRZ in Q2 2013 and held it in 3 quarters. The position peaked at $63M in Q3 2013. 125 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2014.

  • David Abrams reported no remaining Sanofi Contingent Value Rights position as of Q1 2014 after selling out during the quarter.
  • David Abrams sold 11,658,873 Sanofi Contingent Value Rights shares in Q1 2014, an estimated $3.96M.
  • David Abrams first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 3 quarters.
  • David Abrams's Sanofi Contingent Value Rights position peaked at $63M in Q3 2013.
  • 125 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2014.

Based on Abrams Capital Management's 13F filing for Q1 2014, filed 14 May 2014.